How Has The Bio-Implants Market Size Evolved In Recent Years?
The bio-implants market has seen considerable growth due to a variety of factors.
• The size of the bio-implants market has experienced considerable expansion in the past few years. The prediction for its growth goes from $125.48 billion in 2024 to $137.99 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.0%. Various factors such as an aging population and prevalence of chronic diseases, a surge in surgical operations, extended life expectancy, and supportive regulation and standards are responsible for this positive growth in the historical period.
What is the Forecasted Market Size and CAGR for the Bio-Implants Market?
The Bio-Implants market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the bio-implants market is predicted to experience a significant rise in its size, expanding to $210.36 billion by 2029 with a compound annual growth rate (CAGR) of 11.1%.
Factors contributing to the growth during the forecast period include the adoption of customization and personalization, the increase in minimally invasive procedures, the movement towards regenerative medicine, remote monitoring and telemedicine capabilities, as well as a favorable regulatory landscape. Key trends expected during this period involve customized and personalized implants, degradable and resorbable implants, strides in biomaterials technology, developments in regenerative medicine and tissue engineering, as well as smart implants and wearable technologies.
What Key Factors and Trends Are Driving The Growth Bio-Implants Market?
The bio-implant market is forecasted to expand, driven by the rising occurrence of persistent health conditions. Conditions like arthritis and cardiovascular diseases, which last for more than a year, need ongoing medical intervention and limit day-to-day activities, are considered chronic. Bio-implants serve to manage and monitor these chronic conditions, reducing the death rates associated with them. For example, the Australian Institute of Health and Welfare revealed in July 2024 that chronic obstructive pulmonary disease (COPD) led to 7,691 deaths in 2022. This figure equates to 29.6 deaths for every 100,000 individuals, making up 4.0% of all deaths in Australia. Consequently, the upsurge in chronic conditions is driving the growth of the bio-implant market.
What Are The Market Segments In The Bio-Implants Market?
The bio-implants market covered in this report is segmented –
1) By Type: Cardiovascular Implants, Dental Implants, Spinal Bio-Implants, Orthopedic Implants, Ophthalmic Implants, Other Types
2) By Material: Metallic, Ceramic, Polymer, Biological
3) By Origin: Allograft, Autograft, Xenograft, Synthetic
4) By End-User: Ambulatory Surgical Centers, Clinics, Hospital, Other End-Users
Subsegments:
1) By Cardiovascular Implants: Stents, Heart Valves, Pacemakers
2) By Dental Implants: Endosteal Implants, Subperiosteal Implants, Zygomatic Implants
3) By Spinal Bio-Implants: Spinal Fusion Devices, Intervertebral Discs, Spinal Rods And Plates
4) By Orthopedic Implants: Joint Replacement Implants, Fracture Fixation Devices, Bone Plates And Screws
5) By Ophthalmic Implants: Intraocular Lenses (IOLs), Retinal Implants, Corneal Implants
6) By Other Types: Cochlear Implants, Tissue Engineering Implants, Biomaterial Scaffolds
Pre-Book The Bio-Implants Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Bio-Implants Market?
Technological advancements are emerging trends in the bio-implant market, as leading entities focus on developing innovative biomaterial technology, such as 3D printing for bio-implant systems. The 3D-printing technology applied to biomaterials represents a form of additive manufacturing that forms 3D structures capable of functioning as 3D tissues using cells and biomaterials, as opposed to traditional metals and polymers. For example, Evonik Industries AG, a specialty chemicals company based in Germany, introduced the osteoconductive VESTAKEEP iC4800 3DF PEEK filament in March 2022. This product, based on 3D-printing technology, is used for 3D printed implants and promotes osteointegration between the bone and implant, accelerating bone healing. This high-performance polymer is also notable for its exceptional biocompatibility, biostability, and enhanced osteoconductive properties.
Who Are the Key Players In The Bio-Implants Market?
Major companies operating in the bio-implants market include:
• Medtronic PLC
• Stryker Corporation
• Zimmer Biomet Holdings Inc.
• Dentsply Sirona Inc.
• Johnson & Johnson
• Arthrex Inc.
• Boston Scientific Corporation
• Smith & Nephew PLC
• B. Braun Melsungen AG
• Victrex PLC
• Straumann Holding AG
• Danaher Corporation
• Cardinal Health Inc.
• Organogenesis Holdings Inc.
• Exactech Inc.
• Osprey Medical Inc.
• Edwards Lifesciences Corporation
• Biotronik SE & Co. KG
• aap Implantate AG
• Abbott Laboratories
• Biotronik Inc.
• Cook Medical LLC
• Globus Medical Inc.
• Integra LifeSciences Holdings Corporation
• LivaNova PLC
• MicroPort Scientific Corporation
• NuVasive Inc.
• Orthofix Medical Inc.
• RTI Surgical Holdings Inc.
• Terumo Corporation
What Are The Regional Insights Into The Bio-Implants Market?
North America was the largest region in the bio-implants market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bio-implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
